WEBINAR ENDED
Edit
About This Webinar
"Both speakers today were really good. I liked the discussions of how the industry works with detailed real-world examples." - Audience Feedback

Insights and data on Time, Quality, and Cost tradeoffs when expediting time to market. Medical device technology development, commercialization and manufacturing executives share startup and large scale experiences from successes and ongoing projects.

Inspired by a COVID-19 ventilator project condensing 3 years into 3 months for Medical Device Development, experts examine case studies where shortened time to market delivered medical device success without sacrificing quality.

View recording of 90-minute live webinar.
Agenda
  • Right-sizing startup / small company development timing to expedite market entry
  • Design for Supply Chain (DSC) to generate speed: How to optimize cost and speed at the same time
  • Biggest source of FDA warning letters: Areas that most often impact quality when speeding development
  • How to avoid delays during manufacturing transfer
Presenters
1606263735-092ed3166448e14d
Scott Phillips
CEO and Founder - StarFish Medical
Scott is a Chair of the LifeSciences British Columbia board, Fellow of The Canadian Academy of Engineering, winner of the EY Entrepreneur Of The Year™ 2017 Pacific Awards Technology category, 2017 recipient of the VIATEC Technology Champion award, and volunteers with Junior Achievement, Entrepreneurs Organization, and University of British Columbia.
1606264900-7638d9fa799a40c0
Lynne Lowry
Senior Vice President - StarFish Medical
Lynne is a seasoned Business Development Executive in the medical diagnostic industry. Skilled in Sales Management, Sales, Medical Devices, Marketing Management, and Market Analysis, she has held multiple roles in the diagnostic, life science and medical device space in her 30 year career. Prior to joining StarFish Medical, Lynne consulted for product development firms and led global business development teams for Invetech and IDEX Health and Science.
1606265571-1bf4e3e5112e5f31
Kevin Walsh
VP, HealthTech Advanced Technology Solutions at Celestica
Kevin Walsh is Vice President of the HealthTech segment at Celestica. In this role, Kevin is responsible for leading and overseeing the development and strategy for the HealthTech business. He has a thorough understanding of the unique requirements for serving medical device manufacturers including the rigorous quality and regulatory standards required to bring high-reliability products to market.

Kevin joined Celestica in 2000 and has held a number of leadership roles within the organization, and was most recently awarded Celestica’s Ovation Award, which recognizes individuals for their exceptional leadership and contributions to the company.

Kevin is based in Galway, Ireland and holds a Bachelor of Manufacturing Technology degree from the National University of Ireland.
1606265883-449afc3f6c3d14ba
John Walmsley
EVP, Strategic Relationships at StarFish Medical
John is a Professional Physicist and holds a Master of Science in Optics from Queen’s University Belfast. His early career focused on high reliability optoelectronics development and manufacturing transfer. Since joining StarFish in 2005, John has managed projects as diverse as the Canadian Emergency Ventilators project for Canada's Response to COVID-19, 3D ultrasound development, emergency medical devices, and laboratory automation. Previous roles include Chief Operating Officer, responsible for StarFish Medical product development, manufacturing, day to day QA, internal finance, HR and facilities. From 2011-2016, he led StarFish Medical’s product development activities as Vice President of Product Development. John is a frequent speaker at industry events.